4//SEC Filing
INSITE VISION INC 4
Accession 0001209191-15-077359
CIK 0000802724operating
Filed
Oct 29, 8:00 PM ET
Accepted
Oct 30, 11:28 AM ET
Size
5.0 KB
Accession
0001209191-15-077359
Insider Transaction Report
Form 4
Hosseini Kamran
VP, Clinical Affairs & CMO
Transactions
- Disposition from Tender
Common Stock
2015-10-28$0.35/sh−4,353$1,524→ 0 total
Footnotes (1)
- [F1]On October 28, 2015, Thea Acquisition Corp, ("Purchaser"), a wholly owned subsidiary of Ranbaxy, Inc. ("Ranbaxy"), which is an indirect wholly owned subsidiary of Sun Pharmaceutical Industries Ltd., completed a tender offer for all the outstanding shares of InSite Vision Incorporated ("Issuer") for a purchase price of $0.35 per share, all pursuant to that certain Agreement and Plan of Merger, dated September 15, 2015, as amended and restated, by and among Purchaser, Ranbaxy and Issuer.
Documents
Issuer
INSITE VISION INC
CIK 0000802724
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000802724
Filing Metadata
- Form type
- 4
- Filed
- Oct 29, 8:00 PM ET
- Accepted
- Oct 30, 11:28 AM ET
- Size
- 5.0 KB